 |
|
|
| |
Low Risk of Drug-Drug Interactions for Ruzasvir Based Upon In Vitro Metabolism and Transporter Interaction Studies
|
| |
| |
European Association for the Study of the Liver (EASL) 2024 Congress, 5-8 June, Milan, Italy.
Alex Vo,1* Jocelyn Yabut,2 Michael J. Hafey,2 Hui Wan,2 Nancy Agrawal,1 Jean-Pierre Sommadossi1
1Atea Pharmaceuticals, Inc., Boston, MA, USA; 2Merck & Co., Inc., West Point, PA, USA
|
| |
|
|
|
|
|
